Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare TSE:CPH NASDAQ:CRON NYSEARCA:THCX NASDAQ:TLRY On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCPHCipher PharmaceuticalsC$14.26-1.6%C$13.13C$10.61▼C$19.69C$256.01M1.228,341 shs16,780 shsCRONCronos Group$2.48-2.0%$2.09$1.60▼$2.77$969.09M1.012.85 million shs3.21 million shsTHCXAXS Cannabis ETF$16.60$16.60$14.90▼$25.40$141.07M1.7115,071 shsN/ATLRYTilray Brands$1.06-7.0%$0.62$0.35▼$1.95$1.25B1.8579.47 million shs42.33 million shsReduce the RiskMarket downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCPHCipher Pharmaceuticals+1.90%-3.72%+17.52%+17.04%-0.82%CRONCronos Group+6.75%-5.24%+25.87%+21.05%+3.27%THCXAXS Cannabis ETF0.00%0.00%0.00%0.00%0.00%TLRYTilray Brands+10.68%+24.05%+83.49%+151.71%-41.24%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationCPHCipher Pharmaceuticals0.6102 of 5 stars1.20.00.00.01.41.71.3CRONCronos Group1.0907 of 5 stars0.03.00.00.03.30.01.3THCXAXS Cannabis ETFN/AN/AN/AN/AN/AN/AN/AN/ATLRYTilray Brands2.5649 of 5 stars3.11.00.00.03.81.71.3Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCPHCipher Pharmaceuticals 2.33HoldC$14.753.44% UpsideCRONCronos Group 0.00N/AN/AN/ATHCXAXS Cannabis ETF 2.61Moderate Buy$16.60N/ATLRYTilray Brands 2.20Hold$1.9280.82% UpsideCurrent Analyst Ratings BreakdownLatest CPH, THCX, CRON, and TLRY Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails7/29/2025TLRYTilray BrandsZelman & AssociatesSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingNeutral ➝ Neutral(Data available from 8/19/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCPHCipher PharmaceuticalsC$19.03M13.45C$4.04 per share3.53C$3.96 per share3.60CRONCronos Group$117.61M8.08N/AN/A$2.90 per share0.86THCXAXS Cannabis ETFN/AN/AN/AN/AN/AN/ATLRYTilray Brands$210.48M5.54$0.15 per share7.13$1.40 per share0.76Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCPHCipher PharmaceuticalsC$11.41MC$0.9115.75∞N/A59.92%17.93%7.90%N/ACRONCronos Group$41.08M$0.0549.6082.67N/A14.19%-3.78%-3.62%N/ATHCXAXS Cannabis ETFN/AN/A0.00∞N/AN/AN/AN/AN/ATLRYTilray Brands-$2.19B-$2.31N/AN/AN/A-265.69%-6.83%-5.45%10/9/2025 (Estimated)Latest CPH, THCX, CRON, and TLRY EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/7/2025Q2 2025CRONCronos Group-$0.02-$0.10-$0.08-$0.10$45.73 million$33.46 million7/28/2025Q4 2025TLRYTilray Brands-$0.03$0.02+$0.05-$1.30$250.41 million$224.54 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthCPHCipher PharmaceuticalsN/AN/AN/AN/AN/ACRONCronos GroupN/AN/AN/AN/AN/ATHCXAXS Cannabis ETF$0.724.34%N/AN/AN/ATLRYTilray BrandsN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCPHCipher Pharmaceuticals41.222.002.67CRONCronos GroupN/A24.6523.53THCXAXS Cannabis ETFN/AN/AN/ATLRYTilray Brands0.202.461.49Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCPHCipher Pharmaceuticals1.38%CRONCronos Group8.71%THCXAXS Cannabis ETFN/ATLRYTilray Brands9.35%Insider OwnershipCompanyInsider OwnershipCPHCipher Pharmaceuticals42.00%CRONCronos Group6.90%THCXAXS Cannabis ETFN/ATLRYTilray Brands0.60%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCPHCipher Pharmaceuticals517.95 millionN/ANot OptionableCRONCronos Group450383.04 million356.61 millionOptionableTHCXAXS Cannabis ETFN/A8.50 millionN/ANot OptionableTLRYTilray Brands2,8421.10 billion1.09 billionOptionableCPH, THCX, CRON, and TLRY HeadlinesRecent News About These CompaniesTilray Brands (NASDAQ:TLRY) Shares Up 9.2% - Time to Buy?August 19 at 3:11 PM | marketbeat.comPromising Cannabis Stocks To Add to Your Watchlist - August 18thAugust 19 at 2:30 PM | marketbeat.comTilray Brands (NASDAQ:TLRY) Shares Gap Up - Here's WhyAugust 19 at 12:47 PM | marketbeat.comTilray Brands (NASDAQ TLRY) Rises Amid NASDAQ Composite Market TrendsAugust 19 at 8:07 AM | kalkinemedia.comKPromising Cannabis Stocks To Add to Your Watchlist - August 17thAugust 18 at 1:51 PM | marketbeat.comNational Bank of Canada FI Sells 763,247 Shares of Tilray Brands, Inc. $TLRYAugust 18 at 4:15 AM | marketbeat.comTilray Brands (TLRY) Boosts Revenue Mix with New Cannabis, Wellness, and Beverage ProductsAugust 17 at 8:17 PM | insidermonkey.comCannabis Stocks Worth Watching - August 16thAugust 17 at 1:44 PM | marketbeat.comBest Canadian Cannabis Stocks in 2025August 17 at 10:00 AM | marijuanastocks.comMTilray Brands (NASDAQ:TLRY) Trading Down 7.2% - Here's What HappenedAugust 16 at 2:11 PM | marketbeat.comBest Cannabis Stocks To Follow Today - August 15thAugust 16 at 12:32 PM | marketbeat.comTilray Brands, Inc. (TLRY) Declines More Than Market: Some Information for InvestorsAugust 15, 2025 | zacks.comCannabis Stocks Worth Watching - August 14thAugust 15, 2025 | marketbeat.comTilray Brands (NASDAQ:TLRY) Stock Price Down 4.4% - What's Next?August 15, 2025 | marketbeat.comTilray Shares Drop After Seeking Extension to Meet Nasdaq Listing RequirementsAugust 14, 2025 | msn.comTilray Eyes Reverse Stock Split As Nasdaq Listing Compliance Pressure MountsAugust 14, 2025 | finance.yahoo.comTilray Brands: Improving Fundamentals, De-Risked Balance Sheet, And A Re-Igniting NarrativeAugust 14, 2025 | seekingalpha.comTilray Brands (NASDAQ:TLRY) Shares Gap Down - Time to Sell?August 14, 2025 | marketbeat.comTilray Brands Reconfirms Strategy to Regain Nasdaq Compliance; Requests Extension to Meet Listing RequirementsAugust 14, 2025 | globenewswire.comTilray Brands (NASDAQ:TLRY) Shares Up 17.3% - Here's WhyAugust 13, 2025 | marketbeat.comPromising Cannabis Stocks To Add to Your Watchlist - August 13thAugust 13, 2025 | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesWhy the American Eagle Stock Rally Isn't Just Speculation By Gabriel Osorio-Mazilli | July 28, 2025Buffett Makes Big Moves Outside of UNH: A Buy and Sell BreakdownBy Leo Miller | August 18, 20253 Companies That Will Profit From Trump's Semiconductor TariffsBy Jordan Chussler | August 14, 2025Deeply Undervalued, Micron Technologies Stock Isn’t Pricing in AIBy Thomas Hughes | August 14, 2025Micron Stock Still Cheap Despite 25% Rally, Analysts SayBy Gabriel Osorio-Mazilli | August 19, 2025CPH, THCX, CRON, and TLRY Company DescriptionsCipher Pharmaceuticals TSE:CPHC$14.26 -0.23 (-1.59%) As of 04:00 PM EasternCipher Pharmaceuticals Inc is a specialty pharmaceutical company. Its products include Dermatology Products, Hospital Acute Care Products, and Out-Licensed Products among others. The company's geographical segments include Canada and the United States.Cronos Group NASDAQ:CRON$2.48 -0.05 (-1.98%) Closing price 04:00 PM EasternExtended Trading$2.52 +0.04 (+1.41%) As of 07:55 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Cronos Group Inc. operates as a cannabinoid company that engages in the cultivation, production and marketing of cannabis products in Canada, Israel, and Germany. It offers dried flower, pre-rolls, oils, vaporizers, edibles, and cannabis tinctures under the Spinach, Lord Jones, and PEACE NATURALS brands. Cronos Group Inc. was founded in 2012 and is based in Toronto, Canada.AXS Cannabis ETF NYSEARCA:THCX$16.60 0.00 (0.00%) As of 03/1/2024The Cannabis ETF (THCX) is an exchange-traded fund that is based on the AXS Cannabis index. The fund tracks an index of legal cannabis companies selected and weighted by market capitalization. The fund primarily holds North American companies but may also invest in other countries. THCX was launched on Jul 9, 2019 and is managed by AXS Investments.Tilray Brands NASDAQ:TLRY$1.06 -0.08 (-7.02%) Closing price 04:00 PM EasternExtended Trading$1.06 -0.01 (-0.47%) As of 08:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Tilray, Inc. engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc. is headquartered in Canada. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Home Depot Holds Gains After Narrow Q2 Misses Medtronic: The Opportunity Gets Healthier for Income Investors Palo Alto Networks Uptrend Confirmed! New Highs Set by Year’s End Micron Stock Still Cheap Despite 25% Rally, Analysts Say Qualcomm Just Passed 1 Major Test, But Can It Pass the Next? DLocal Stock Soars 43% After Earnings Beat and Raised Guidance D-Wave Buying Spree: Will These Firms Be Potential Targets? Lyft's Billion-Dollar Signal: Why Wall Street Is Betting Big Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.